Individual and Peer Factors Associated with Ketamine Use Among Adolescents in Taiwan
Overview
Psychiatry
Authors
Affiliations
The aim of this cross-sectional study was to examine the individual (demographic characteristics, substance-using behaviors, emotional status, and negative outcome expectancy) and peer factors associated with ketamine use in Taiwanese adolescents. A total of 9,860 adolescents completed the self-report questionnaires without omission. Demographic characteristics, substance-using behaviors, emotional status, negative outcome expectancy, and peer factors were compared between the ketamine users and non-users using the Mann-Whitney U test and the Chi-square test, and then significant factors were further selected for stepwise logistic regression analysis to examine the associated factors of ketamine use. Sixty-nine (0.7%) participants reported having used ketamine in the past year. The results of logistic regression analysis indicated that ketamine users were more likely to use marijuana, smoke cigarettes, have peers using illicit drugs, and have a lower level of negative outcome expectancy regarding using ketamine than ketamine non-users. The associated factors found in this study should be taken into consideration when developing prevention and intervention programs for ketamine use in adolescents.
Mis-anaesthetized society: expectancies and recreational use of ketamine in Taiwan.
Chang C, Wu T, Ting T, Chen C, Su L, Chen W BMC Public Health. 2019; 19(1):1307.
PMID: 31623586 PMC: 6798441. DOI: 10.1186/s12889-019-7616-1.
Wang L, Chen M, Lin C, Chong M, Chou W, You Y Subst Abuse Treat Prev Policy. 2018; 13(1):50.
PMID: 30577882 PMC: 6303878. DOI: 10.1186/s13011-018-0188-8.
Wang L, Lu S, Chong M, Chou W, Hsieh Y, Tsai T Neuropsychiatr Dis Treat. 2016; 12:699-706.
PMID: 27099500 PMC: 4820190. DOI: 10.2147/NDT.S105199.
Wang Y, Wu A, Lau J BMC Public Health. 2016; 16:272.
PMID: 26983882 PMC: 4794899. DOI: 10.1186/s12889-016-2947-7.
Wang L, Lu S, Chou W, Chong M, Wang Y, Hsieh Y Neuropsychiatr Dis Treat. 2015; 11:1921-7.
PMID: 26261419 PMC: 4527575. DOI: 10.2147/NDT.S84562.